Elite Pharma Financials

ELTPDelisted Stock  USD 0.04  0  6.75%   
Based on the key measurements obtained from Elite Pharma's financial statements, Elite Pharma is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.
With this module, you can analyze Elite financials for your investing period. You should be able to track the changes in Elite Pharma individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
  
Understanding current and past Elite Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Elite Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Elite Pharma's assets may result in an increase in income on the income statement.
The data published in Elite Pharma's official financial statements typically reflect Elite Pharma's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Elite Pharma's quantitative information. For example, before you start analyzing numbers published by Elite accountants, it's essential to understand Elite Pharma's liquidity, profitability, and earnings quality within the context of the Pharmaceuticals space in which it operates.

Elite Pharma Stock Summary

Elite Pharma competes with Intelgenx Technologs, and Cytosorbents Crp. Elite Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and manufacture of oral, controlled-release products and generic pharmaceuticals. The company was incorporated in 1997 and is headquartered in Northvale, New Jersey. Elite Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 43 people.
Specialization
Healthcare, Drug Manufacturers - Specialty & Generic
InstrumentUSA OTC Stock View All
ExchangeOTCQB Exchange
ISINUS28659T2006
CUSIP28659T200
LocationNew Jersey; U.S.A
Business Address165 Ludlow Avenue,
SectorPharmaceuticals
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.elitepharma.com
Phone201 750 2646
CurrencyUSD - US Dollar

Elite Pharma Key Financial Ratios

Elite Pharma's financial ratios allow both analysts and investors to convert raw data from Elite Pharma's financial statements into concise, actionable information that can be used to evaluate the performance of Elite Pharma over time and compare it to other companies across industries.

Elite Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Elite Pharma's current stock value. Our valuation model uses many indicators to compare Elite Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elite Pharma competition to find correlations between indicators driving Elite Pharma's intrinsic value. More Info.
Elite Pharma is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.27  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Elite Pharma is roughly  3.71 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elite Pharma's earnings, one of the primary drivers of an investment's value.

Elite Pharma Market Pulse

 Quote0.0373
 Change(%)  6.75 
 Change
 Open0.04
 Low0.0362
 High0.04
 Volume0
 ExchangeOTCQB

Elite Pharma Thematic Clasifications

Elite Pharma is part of Pharmaceutical Products investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions
Pharmaceutical ProductsView
This theme covers USA Equities from Pharmaceutical Products industry as classified by Fama & French. Fama and French investing themes focus on testing asset pricing under different economic assumptions. Get More Thematic Ideas

Elite Pharma November 26, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Elite Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Elite Pharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of Elite Pharma based on widely used predictive technical indicators. In general, we focus on analyzing Elite OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Elite Pharma's daily price indicators and compare them against related drivers.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Consideration for investing in Elite OTC Stock

If you are still planning to invest in Elite Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Elite Pharma's history and understand the potential risks before investing.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency